Literature DB >> 9497500

The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes.

C Frohn1, P Schlenke, H Kirchner.   

Abstract

Over the last few years, natural killer (NK) cells have been shown to express major histocompatibility complex (MHC) molecules recognizing receptors that are thought to function primarily as negative signalling receptors. Much attention has been focused on the NK cell receptors CD158a (EB6) and CD158b (GI 183), which recognize two alternative epitopes on the HLA-Cw locus. In order to investigate whether HLA type affects the CD158a/b repertoire, expressed as percentage positive cells for a particular receptor and mean expression on this population of NK cells, peripheral blood lymphocytes of 47 HLA-typed donors were examined. Peripheral blood samples were examined by flow cytometric analysis to investigate the expression of CD158a and CD158b receptors on the surface of NK cells. In parallel, we determined each individual's HLA phenotype. There was a great heterogeneity in CD158 expression; nevertheless all individuals had NK cells belonging either to the CD158 a+b-, a-b+ or a-b- populations. No positive or inverse correlations could be shown between either receptor expression intensity or proportion of positive cells, and presence of the appropriate ligand. Thus no association between an individual's NK receptor repertoire and HLA serotype could be demonstrated. It is concluded that CD158 is expressed on NK cells in a highly redundant fashion. Our data do not support either a positive selection mechanism or the receptor calibration model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9497500      PMCID: PMC1364164          DOI: 10.1046/j.1365-2567.1997.00374.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.

Authors:  E W Petersdorf; G M Longton; C Anasetti; E M Mickelson; S K McKinney; A G Smith; P J Martin; J A Hansen
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

2.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

3.  Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells.

Authors:  M Vitale; S Sivori; D Pende; L Moretta; A Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

4.  HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.

Authors:  M Colonna; G Borsellino; M Falco; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

Review 5.  Invertebrate immune recognition, natural immunity and the evolution of positive selection.

Authors:  T Humphreys; E L Reinherz
Journal:  Immunol Today       Date:  1994-07

6.  Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand.

Authors:  M Y Olsson; K Kärre; C L Sentman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).

Authors:  H H Peter; J Pavie-Fischer; W H Fridman; C Aubert; J P Cesarini; R Roubin; F M Kourilsky
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

8.  H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains.

Authors:  C L Sentman; M Y Olsson; M Salcedo; P Höglund; U Lendahl; K Käre
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

9.  Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing.

Authors:  A M Nouri; R F Hussain; A V Dos Santos; M Mansouri; R T Oliver
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

10.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.

Authors:  J E Gumperz; V Litwin; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  8 in total

1.  HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells.

Authors:  Zaheed Husain; Edward Levitan; Charles E Larsen; Nadeem M Mirza; Souhad Younes; Edmond J Yunis; Chester A Alper; Devendra P Dubey
Journal:  J Clin Immunol       Date:  2002-01       Impact factor: 8.317

2.  Complex expression of natural killer receptor genes in single natural killer cells.

Authors:  Zaheed Husain; Chester A Alper; Edmond J Yunis; Devendra P Dubey
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

3.  Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

Authors:  Katharine C Hsu; Carolyn A Keever-Taylor; Andrew Wilton; Clara Pinto; Glenn Heller; Knarik Arkun; Richard J O'Reilly; Mary M Horowitz; Bo Dupont
Journal:  Blood       Date:  2005-02-24       Impact factor: 22.113

4.  Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.

Authors:  J Clausen; D Wolf; A L Petzer; E Gunsilius; P Schumacher; B Kircher; G Gastl; D Nachbaur
Journal:  Clin Exp Immunol       Date:  2007-06       Impact factor: 4.330

5.  Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.

Authors:  T Kogure; H Fujinaga; A Niizawa; L X Hai; Y Shimada; H Ochiai; K Terasawa
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

6.  The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.

Authors:  Toshiaki Kogure; Naoki Mantani; Hirozo Goto; Yutaka Shimada; Jun'ichi Tamura; Katsutoshi Terasawa
Journal:  Mediators Inflamm       Date:  2002-08       Impact factor: 4.711

7.  No correlation exists between disease activity and the expression of killer-cell immunoglobulin-like receptors in patients with rheumatoid arthritis.

Authors:  Toshiaki Kogure; Takeshi Tatsumi; Atsushi Niizawa; Hiroshi Fujinaga; Tomoyuki Ito; Yutaka Shimada; Katsutoshi Terasawa
Journal:  Mediators Inflamm       Date:  2006-12-27       Impact factor: 4.711

8.  Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.

Authors:  Toshiaki Kogure; Naoki Mantani; Shinya Sakai; Yutaka Shimada; Jun'ichi Tamura; Katsutoshi Terasawa
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.